|
|
||||||||
The Journal of Neurophysiology Vol. 87 No. 2 February 2002, pp. 696-704
Copyright ©2002 by the American Physiological Society
Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta T6G 2S2, Canada
| |
ABSTRACT |
|---|
|
|
|---|
Jhamandas, Jack H., Kim H. Harris, David MacTavish, and Balvinder S. Jassar. Novel Excitatory Actions of Galanin on Rat Cholinergic Basal Forebrain Neurons: Implications for Its Role in Alzheimer's Disease. J. Neurophysiol. 87: 696-704, 2002. Galanin, a 29-amino-acid neuropeptide, is generally viewed as an inhibitory neuromodulator in a variety of central systems. Galanin expression is upregulated in the cholinergic basal forebrain nuclei in Alzheimer's disease (AD) and is postulated to play an important role in memory and cognitive function. In this study, application of galanin to acutely dissociated rat neurons from the basal forebrain nucleus diagonal band of Broca (DBB), caused a decrease in whole cell voltage-activated currents in a majority of cells. Galanin reduces a suite of potassium currents, including calcium-activated potassium (IC), the delayed rectifier (IK), and transient outward potassium (IA) conductances, but not calcium or sodium currents. Under current-clamp conditions, application of galanin evoked an increase in excitability and a loss of accommodation in cholinergic DBB neurons. Using single-cell RT-PCR technique, we determined that galanin actions were specific to cholinergic, but not GABAergic DBB neurons The notion that galanin plays a deleterious role in AD is based, in part, on galanin hyperinnervation of cholinergic cells in the basal forebrain of AD patients, its ability to depress acetylcholine release and its inhibitory actions at other CNS sites. However, our results suggest that by virtue of its excitatory actions on cholinergic neurons, galanin may in fact play a compensatory role by augmenting the release of acetylcholine from remaining cholinergic basal forebrain neurons. This action might serve to delay the progression of AD pathology linked to a reduction in central cholinergic tone.
| |
INTRODUCTION |
|---|
|
|
|---|
Galanin, a 29-amino-acid
peptide, was first isolated from pig small intestine (Tatemoto
et al. 1983
) and is widely distributed in the peripheral and
central nervous systems (Melander et al. 1986
;
Skofitsch and Jacobowitz 1985
). The presence of galanin within dense core vesicles of nerve terminals and its
stimulus-dependent release has suggested a
neurotransmitter/neuromodulatory role for this peptide (Bartfai
et al. 1993
; Consolo et al. 1994
). Recently, three distinct receptors for galanin have been cloned and identified to
belong to seven-transmembrane G-protein-coupled family of receptors (for review, see Branchek et al. 2000
). However, selective antagonists have yet to be found for any of the three cloned receptors.
In general, galanin has been identified to be an inhibitory peptide on
the basis of its hyperpolarizing actions on neurons of the cardiac
ganglia, locus coeruleus, dorsal raphe, hypothalamic supraoptic
nucleus, and the CA3 region of the hippocampus (Konopka et al.
1989
; Papas and Bourque 1997
; Pieribone
et al. 1995
; X. J. Xu et al. 1995
;
Z. Q. Xu et al. 1999
). In the hypothalamus, galanin
also inhibits the depolarizing afterpotential that sustains bursting in
magnocellular neurosecretory cells (Papas and Bourque 1997
) and presynaptically depresses glutamate-mediated
excitation of arcuate neurons (Kinney et al. 1998
).
Pharmacological experiments that examine transmitter release are less
clear on the predominantly inhibitory effects observed at a cellular
level. For example, galanin inhibits acetylcholine (ACh) release in the
rat ventral hippocampus and from slices of the cerebral cortex
(Fisone et al. 1987
; Wang et al. 1999
),
whereas it is stimulates ACh release in the rat striatum (Amorso
et al. 1992
; Pramanik and Ogren 1993
).
Galanin-immunoreactive cell bodies, fibers, and terminals and galanin
receptors are located in the basal forebrain nuclei of rats, monkeys,
and humans (Kohler and Chan-Palay 1990
; Melander et al. 1986
; Merchantaler et al. 1993
). In
particular, galanin-positive synapses have been identified on
cholinergic neurons in the lateral part of the nucleus of the diagonal
band of Broca (DBB), a basal forebrain nucleus (Henderson and
Morris 1997
). However, the source for the galanin input to
cholinergic neurons is unknown at present. The cholinergic neurons in
DBB and other forebrain nuclei are selectively lost in
neurodegenerative conditions such as Alzheimer's disease (AD)
(Price 1986
). The degree of loss of cholinergic neurons in the basal forebrain and cholinergic markers in the cortex strongly correlates with the behavioral and cognitive deficits seen in AD
(Price 1986
). The role of galanin in AD is
controversial. Galaninergic innervation of remaining basal forebrain
cholinergic neurons is augmented in AD (Bowser et al.
1997
). Given its inhibitory effects on ACh release in the
hippocampus, this galanin hyperinnervation of cholinergic basal
forebrain neurons is postulated to depress septo-hippocampal circuits
involve in learning and memory (Mufson et al. 1998
). On
the other hand, administration of nerve growth factor (NGF), a
target-derived growth factor that is important for growth and survival
of cholinergic basal forebrain neurons, increases the gene expression
of galanin (Planas et al. 1997
) and raises the
possibility that induction of galanin by NGF may have a neuroprotective
role. Investigation of the cellular mechanism of action of this peptide
in the cholinergic basal forebrain may thus provide a better
understanding of its role in the pathology in AD.
In this study, we investigated the actions of galanin on acutely dissociated rat cholinergic basal forebrain neurons from the nucleus of the DBB using a combination of whole cell patch-clamp and single-cell reverse transcription-polymerase chain reaction (RT-PCR) analysis. Our data show that the blockade of specific potassium conductances is a potential underlying mechanism for the action of galanin on DBB neurons and may explain its effects in regulating their excitability.
| |
METHODS |
|---|
|
|
|---|
Dissociation procedures
Details of the procedure for acute dissociation of neurons from
the DBB are described in Jassar et al. (1999)
. Briefly,
brains were quickly removed from decapitated male Sprague-Dawley rats (15-25 day postnatal) and placed in cold artificial cerebrospinal fluid (ACSF) that contained (in mM) 140 NaCl, 2.5 KCl, 1.5 CaCl2, 5 MgCl2, 10 HEPES,
and D-glucose 33 (pH 7.4). Brain slices (350-µm thick)
were cut on a vibratome, and the area containing the DBB was dissected
out. Although most of the tissue contained the horizontal limb of the
DBB, some slices may have included a component of the vertical limb of
the DBB. Acutely dissociated neurons were prepared by enzymatic
treatment of slice with trypsin (0.65 mg/ml) at 30°C, followed by
mechanical trituration for dispersion of individual cells. Cell were
then plated on poly-L-lysine (0.005% wt/vol)-coated cover
slips and viewed under an inverted microscope (Zeiss Axiovert 35). All
solutions were kept oxygenated by continuous bubbling with pure oxygen.
Electrophysiological recordings
Whole cell patch-clamp recordings were performed at room
temperature (20-22°C) using an Axopatch-1D amplifier. Patch
electrodes (World Precision Instruments, thin wall with filament,
1.5-mm diam) were flame polished to yield resistances of 3-6 M
.
Internal patch pipette solution contained (in mM) 140 K-methylsulfate, 10 EGTA, 5 MgCl2, 1 CaCl2,
10 HEPES, 2.2 Na2-ATP, and 0.3 Na-GTP (pH 7.2).
Junction potential was nulled with the pipette tip immersed in the
bath. Putative acutely dissociated DBB neurons were initially identified for recording by visual inspection. Current-voltage relationships and excitability characteristics were used to distinguish neurons from glial or other cell types (Jassar et al.
1999
). Whole cell recordings were also done in the bridge
current-clamp mode using an Axoclamp-2B amplifier to examine the
effects of galanin on current-evoked changes in excitability of the
acutely dissociated DBB neurons. Action potentials were evoked by brief
current injection (0.6-1.5 nA, 600-ms duration) through the patch
pipette. The resting membrane potential (RMP), number of spikes
elicited, and interspike intervals were recorded for comparison under
different experimental conditions. The membrane currents (voltage-clamp
experiments) or the membrane voltages (current-clamp experiments) were
recorded and analyzed on computer using pCLAMP software (version
6.0.3).
After whole cell configuration was established, we waited
5 min for
steady-state currents to stabilize. The filter was set at 20 kHz during
data acquisition. Cells were held in voltage clamp at
80 mV, which
was close to the RMP observed in earlier studies on neurons from basal
forebrain slices (Alonso et al. 1994
; Easaw et
al. 1997
). A 1-s-long hyperpolarizing command to
110 mV was
applied to remove inactivation of K+ channels so
that the maximum current could be activated during the subsequent slow
voltage ramp to +30 mV (20 mV/s) that followed it. No obvious tail
currents were observed at the end of the ramp when the command
potential was returned to
80 mV, suggesting that the ramp elicited
mainly steady-state currents.
Cell size was estimated electronically using the whole cell capacitance
compensation circuit on the Axopatch-1D amplifier. Series resistance
compensation was continuously adjusted to >80% and monitored and
readjusted as necessary during the course of each experiment. The
average series resistance (electrode plus access resistance) was
7.3 ± 0.5 M
(n = 51). Maximum voltage-clamp error in recording a current of 10 nA using a patch electrode with an
electrode resistance of 8 M
was 16 mV. This reflects the average
maximum error because the currents recorded were usually <10 nA. In
figures displaying difference currents, capacitance transients have
been truncated.
To examine the effects of galanin on the contribution of
Ca2+ to voltage-dependent ionic currents, we
utilized an external solution which was nominally
Ca2+-free and contained 50 µM
Cd2+. In this solution,
CaCl2 was replaced with an equimolar
concentration of MgCl2. To record currents
through calcium channels, we used Ba2+ as a
charge carrier as previously described (Easaw et al.
1999
). The external solution contained (in mM) 150 tetraethylammonium chloride, 2 BaCl2, 10 HEPES,
and 30 glucose (pH to 7.4 with TEA-OH). The internal patch pipette
solution consisted of (in mM) 130 Cs-methanesulfonate, 2 MgCl2, 10 HEPES, 10 BAPTA, 4 Mg-ATP, 0.2 Na-GTP,
and 0.1 leupeptin (pH to 7.2 with CsOH). Depolarizing voltage steps
from
80 to +70 mV (increment, 10 mV/step; 20-ms duration) were
applied to voltage-clamped DBB neurons under control conditions and in
the presence of galanin. Leak currents were minimal under our recording conditions. They did not change during the recordings and were not
affected by application of galanin. Therefore we did not subtract these
in subsequent measurements of steady-state barium or calcium currents.
We also studied the effects of galanin on
INa. To isolate
INa, the external solution contained
(in mM) 125 NaCl, 20 TEA-Br (to block K+
currents), 2 MgCl2, 5 MnCl2
(to block Ca2+ currents), 10 HEPES, and 20 glucose (pH 7.4 with Tris-OH), and the internal solution consisted of
(in mM) 130 cesium-methanesulfonate, 10 HEPES, 10 BAPTA, 5 Mg-ATP, and
0.3 Na2-GTP (pH 7.2 with Cs-OH). The currents
were evoked by 10-ms voltage steps from
80 mV to a maximum of +60 mV
(increment, 10 mV/step; 10-ms duration) in the presence and absence of galanin.
Drugs and solutions
Galanin and galantide (M15) were obtained from Bachem (Torrance,
CA) and iberiotoxin from Sigma Chemical (St. Louis, MO). All the agents
were dissolved in distilled water to make 1,000× stock solution
(stored at
70°C) and diluted in external perfusing medium just
before the time of application. All drugs and chemicals were applied
via bath perfusion at the rate of 3-5 ml/min, which allowed complete
exchange in <0.5 min. Data are presented as means ± SE.
Student's two-tailed t-test was utilized for determining significance of effect.
Single-cell RT-PCR for chemical phenotyping
Neurons were harvested after electrophysiological recordings
were completed and readied for RT-PCR according to a previously described protocol (Surmeier et al. 1996
). In brief,
contents of the electrode containing the cell and 5 µl of internal
solution were expelled into a 0.2 ml PCR tube containing 5 µl sterile
water (Sigma water W-4502), 0.5 µl dithiothreitol 0.1 M (DTT), 0.5 µl RNasin (10 U/µl), and 1 µl oligo-dT (0.5 µg/µl). The tube
was then placed on ice. Single-stranded cDNA was then synthesized from
mRNA by adding a solution containing 1 µl SuperScript II RT (200 U/µl), 2 µl 10 × PCR buffer, 2 µl 25 mM
MgCl2, 1.5 µl 0.1 M DTT, 1 µl 10 mM dNTPs,
and 0.5 µl RNasin (10 U/µl). The PCR tube was gently mixed and
incubated in a Techne Progene thermal cycler at 42°C for 50 min. The
process was then terminated by heating to 72°C for 15 min, and the
tube cooled to 4°C. Subsequently 2 µl of the RT product was taken
and combined with 5 µl 10 × PCR buffer, 5 µl 25 mM
MgCl2, 0.5 µl Taq polymerase (5 U/µl), 31.5 µl sterile water (sigma water W-4502), 1 µl 25 mM
dNTP mixture, and 1.5 µl of a specific set of primers (15 µM). All
reagents were purchased from GibcoBRL. Primer sequences for choline
acetyltransferase (ChAT) and for glutamate decarboxylase (GAD) have
been previously described (Surmeier et al. 1996
;
Tkatch et al. 1998
) and that for
-actin was obtained
from GenBank (the lower primer 5'-GAT AGA GCC ACC AAT CCA C, the upper
primer 5'-CCA TGT ACG TAG CCA TCC A). All primers were synthesized at
the University of Alberta Department of Biochemistry. The contents were
mixed together and placed in the thermal cycler. The PCR amplification
protocol was as follows: step 1: 94°C 4 min; step
2: 94°C 1 min, 53°C 1 min, 72°C 45 s (step 2 was repeated 35 times); step 3: 72°C 15 min; step
4: held at 4°C. A portion of the product was then run on a 2%
TEA agarose gel, and the gel was then placed in a bath containing 2 µg/ml of ethidium bromide, after 10 min DNA bands were visualized with UV light box and photographed with a Polaroid camera.
| |
RESULTS |
|---|
|
|
|---|
Most of the acutely dissociated neurons from the DBB had
neuron-like morphology (i.e., large cells with a conspicuous nucleus, nucleolus and a few blunt processes which were truncated
axon/dendrites). The average membrane capacitance estimated
electronically on the Axopatch-1D amplifier was 17.8 ± 0.3 pF
(n = 134). Under our recording conditions, the average
input conductance measured from the slope of the I-V
relationships between
60 and
110 mV was 0.82 ± 0.18 nS
(n = 51).
Based on the previous observations (Jassar et al. 1999
),
we utilized a voltage-ramp protocol where the cells were held at
80
mV and subjected to voltage ramps from
110 to +30 mV at the rate of
20 mV/s after conditioning at
110 mV for 1 s.
Effects of galanin on whole cell potassium currents in DBB neurons
The concentration of galanin (300 nM) used in the present
experiment was based on previous electrophysiological studies of this
peptide in acutely dissociated neurons (300 nM) (Puttick et al.
1994
) or in brain slices (range, 100 nM-1 µM) (Kinney
et al. 1998
; Papas and Bourque 1997
; Xu
et al. 1999
). Figure
1A shows the voltage-activated
currents recorded from a DBB neuron under control conditions, in the
presence of galanin (300 nM), and recovery after washout. Application
of galanin resulted in a decrease in whole cell currents in the
30 to
+30 mV range in 51 of 75 cells. In these cells, the amplitude of the
currents at +30 mV was significantly reduced from 6.5 ± 0.3 nA
under control conditions to 5.4 ± 0.2 nA (n = 51;
P < 0.001) in the presence of galanin; this represents a decrease of 16.1 ± 1.2% at this potential. In 24 cells,
galanin application either did not evoke any a change in whole cell
current or caused an increase or decrease in the whole cell current
that was <5% from control values at +30 mV.
|
Under our recording conditions, currents that are activated in the
voltage range in which galanin exerts its actions include the classical
Hodgkin-Huxley type delayed rectifier
(IK) and the calcium-activated
potassium (IK,Ca) currents. The fast
inactivation kinetics of the transient outward potassium current
(IA) (Belluzzi et al.
1985
; Cooper and Shrier 1985
;
Griffith and Sim 1990
) makes it unlikely that these
channels are activated during the relatively slow voltage ramps
utilized in our experiments. This suggests that under these conditions
the conductances affected by galanin include
IK and/or
IK,Ca.
Chemical identity of galanin responsive DBB neurons
Within the DBB, there are two main chemical neurotransmitter
phenotypes of neurons
GABAergic and cholinergic. Definitive
determination of the chemical phenotype was done by RT-PCR analysis.
ChAT was used as a specific marker for cholinergic neurons, and GAD was used as a specific marker for GABAergic neurons. Figure 1B
shows the photograph of a gel indicating RT-PCR product from a galanin responsive cell on the left (band corresponding to the molecular weight
of the ChAT primer) and a galanin unresponsive neuron on the right
(band corresponding to the molecular weight of GAD primer). Results
from 21 DBB neurons recorded under voltage- or current-clamp modes and
in which the PT-PCR reaction was unequivocal indicate that 17 galanin-responsive cells were ChAT positive and GAD negative. Four
galanin unresponsive neurons were GAD positive and ChAT negative.
Effects of the blockade of calcium influx
Because the IK,Ca currents are
activated by Ca2+, which flows into the cell
during the depolarizing phase of the action potential, their
contribution to the voltage-activated conductances can be assessed by
blocking Ca2+ influx (Lancaster et al.
1991
). This was achieved by replacing the extracellular
Ca2+ with Mg2+.
Cd2+ (50 µM) was included in the external
perfusing solution to ensure complete blockade of the
Ca2+ influx. Figure
2A shows the average of
current-voltage relationships obtained from eight neurons under control
conditions, with 0 mM Ca2+ and 50 µM
Cd2+ in the external medium, galanin in the
presence of 0 mM Ca2+ and 50 µM
Cd2+, and recovery. Replacing the external
solution with 0 mM Ca2+ and 50 µM
Cd2+ decreased the currents measured at +30 mV by
19.4 ± 3.4% (control = 5.4 ± 0.5 nA; 0 mM
Ca2+ and 50 µM Cd2+ = 4.4 ± 0.5 nA). Application of galanin in the presence of 0 mM
Ca2+ and 50 µM Cd2+
further reduced the currents by 4.9 ± 1.2% (0 mM
Ca2+ and 50 µM Cd2+ with
galanin = 4.1 ± 0.5 nA, P < 0.01). Thus
although a significant amount of the galanin response was blocked in
the presence of 0 mM Ca2+ and 50 µM
Cd2+, a small but persistent reduction in
currents remained under these conditions. This suggests that the
effects of galanin are in part mediated via a
Ca2+-dependent K+ current.
|
Effects of blocking calcium-activated potassium currents (IK,Ca) on the galanin response
The contribution of IK,Ca or
IC (BK channels) to the
voltage-activated currents can be determined by using the selective
blockers of this family of voltage-sensitive calcium-activated
potassium channels. The more sensitive and specific ones are:
iberiotoxin (IBTX; IC50 = 0.25 nM) (Galvez
et al. 1990
), a snail toxin from Buthus tamulus.
Figure 2B shows the an average of voltage-ramp relationship
of currents from 13 cells evoked under control conditions, with galanin
(300 nM) alone, with IBTX (25 nM) alone, and with a combination of
galanin and IBTX. Galanin or IBTX applied individually and sequentially
caused a reduction in outward currents in the same voltage range (
40
to +30 mV). Control currents were decreased 15.1 ± 3.1% by
galanin alone (control = 7.8 ± 0.4 nA; galanin = 6.6 ± 0.4 nA) and 21 ± 5.6% by IBTX alone (control = 7.4 ± 0.5 nA; IBTX = 5.7 ± 0.4 nA). When galanin was
applied in the presence of IBTX, there was an additional significant
reduction in current (9.0 ± 2.3%, P < 0.001).
Thus the galanin-evoked decrease in whole cell currents are partly
mediated through an IBTX-sensitive calcium-activated potassium
conductance. The inset in Fig. 2B also
illustrates another important point, namely that the galanin-evoked
reduction of whole cell currents under control conditions is a
time-independent response. Three sequential applications of galanin, 10 min apart, did not show a significantly different magnitude of response
(n = 6, P > 0.6), indicating that the
galanin response does not desensitize with repeated applications.
The IBTX-induced decrease in the currents occurred in the same voltage range and was of a similar magnitude as that obtained by omitting calcium in the external perfusing medium (see Fig. 2A). Collectively, these data support the specificity and efficacy of 25 nM IBTX in blocking voltage-sensitive calcium-activated K+ currents in our preparation.
Blockade of galanin response with TEA
TEA ions at a concentration of 5 mM block
IK and
IC (Jassar et al.
1999
). Figure 2C shows the average current-voltage
relationships obtained from six DBB neurons under control conditions,
in the presence of 5 mM TEA, and galanin in the presence of TEA. TEA blocked 74.3 ± 0.9% of the outward current at +30 mV
(control = 7.3 ± 0.8 nA, TEA = 1.7 ± 0.2 nA,
n = 6). Galanin failed to produce any significant
effect on the remaining currents in the presence of TEA (TEA + galanin = 1.7 ± 0.2 nA, n = 6, P = 0.64).
Galanin has no effect on barium currents
Because galanin blocks IC, one
possible target of action can be the voltage-gated calcium channels
through which the calcium influx responsible for the activation of
IC occurs. Currents through calcium
channels were recorded using Ba2+
(IBa) as the charge carrier. The use
of Ba2+ as a charge carrier has advantages over
Ca2+ as it avoids
Ca2+-induced inactivation of
Ca2+ channels and is a better charge carrier
(Griffith et al. 1994
). Figure 2D shows an
average of barium currents flowing through calcium channels evoked in
16 DBB neurons under control conditions and subsequently in the
presence of galanin. The inset shows the effects of galanin
on IBa evoked by applying a 25-ms step
command to
10 mV from a holding potential of
90 mV. The maximum
current-density was 96.0 ± 10.2 pA/pF at 0 mV under control
conditions (n = 16) in this group of cells. Galanin did
not affect the whole cell IBas at any
voltage between
80 and +70 mV. The whole cell
IBas at 0 mV were not significantly
different from those under control conditions (control: 2.0 ± 0.1 nA; galanin: 1.9 ± 0.1 nA; n = 16, P > 0.05). Although three different kinds of
voltage-gated calcium channels have been shown to be present in the rat
magnocellular cholinergic basal forebrain neurons (Allen et al.
1993
; Jassar et al. 1999
), because of the
absence of effects of galanin, it was deemed unnecessary to carry out
any further biophysical or pharmacological characterization of
Ca2+ currents.
Effects of galanin on transient outward (IA) and the delayed rectifier (IK) potassium currents
IA and
IK are voltage-sensitive currents, and
their activation and inactivation are strongly voltage dependent.
IA requires the holding potential to
be relatively hyperpolarized (approximately
110 mV) for removal
of its inactivation, whereas it is inactivated at
40 mV. On the other
hand, IK is not inactivated at
40
mV. These biophysical properties of IA
and IK can, thus be utilized to
isolate these currents. Therefore a conditioning pulse to
40 mV will
activate IK without any significant
contamination by IA (Connor and
Stevens 1971
; Easaw et al. 1999
). A conditioning
pulse to
120 mV will activate both
IA and
IK. The difference currents obtained
by subtracting the currents evoked by depolarizing pulses following a
conditioning pulse to
40 mV from those evoked following a
conditioning pulse to
120 mV provide an accurate estimate of IA. Figure
3A shows the currents recorded
from a DBB neuron with a conditioning pulse to
40 mV for 150 ms,
representing mainly IK, under control
conditions, in the presence of galanin and recovery on washout of
galanin. Galanin reduced IK by
9.2 ± 1.8% (control = 9.8 ± 0.5 nA, galanin = 9.1 ± 0.1.8 nA, n = 27, P < 0.001 at +30 mV). Figure 3B shows the difference currents
recorded from the same neuron representing mainly
IA, under control conditions, in the
presence of galanin and on washout. IA
was reduced significantly by galanin by 15.1 ± 4.1% in 18 of 27 cells (control = 5.0 ± 0.5 nA, galanin = 4.2 ± 0.4 nA, n = 18, P < 0.001). We have
previously shown that the residual sustained current remaining at the
end of the 100-ms test pulse (shown in Fig. 3B) consists
mainly of IK and
IC (Easaw et al. 1999
),
both of which are also reduced by galanin. Figure 3, C and
D, shows the current-voltage relationships of averaged peak
IK (n = 27) and
IA (n = 18),
respectively, using the voltage step protocols shown in Fig. 3,
A and B. Galanin did not affect the activation
characteristics of IA (data not
shown).
|
Effects of galanin on sodium currents
Sodium currents are involved in the fast depolarizing phase of the
action potential. Enhancement of these currents can increase the
excitability and vice versa. We recorded sodium currents in isolation
to assess if galanin has any effects on these currents. The sodium
currents were TTX-sensitive. The current-voltage relationships obtained
from 7 cells reveal that galanin did not influence sodium currents in
DBB neurons (control =
5.2 ± 0.4 nA, galanin =
5.2 ± 0.3 nA, P = 0.3 at +20 mV, not illustrated).
Effects of galanin on action potentials and excitability
We performed bridge current-clamp recordings in whole cell mode to examine the effects of galanin on DBB neurons. In addition, we also determined whether the galanin-induced changes in excitability that could be predicted from the observed decrease in currents through IC channels that it produces under voltage-clamp conditions.
Figure 4A shows the trains of
action potentials generated by injecting a 600-ms current pulse (1.0 nA) under control conditions, in the presence of galanin (300 nM), and
on washout (recovery). The number of spikes generated by a 600-ms
depolarizing current pulse was 8 ± 1.2 under control conditions
and 13.5 ± 1.1 in the presence of galanin (n = 13, P < 0.001) and a recovery to near control values
(6.7 ± 1.5). The ratio of interspike interval between the first
two and the last two action potentials provides a measure of
accommodation. A ratio approaching one indicates loss of accommodation. Under control conditions, this ratio was 0.56 ± 0.05 (n = 13), and it increased to 0.73 ± 0.04 (n = 13) in the presence of galanin (P < 0.01), indicating attenuation of accommodation in the presence of
the peptide (Fig. 4B). On recovery, the ratio was 0.54 ± 0.04. Because IC channels govern,
in part, spike adaptation and excitability (Vergara et al.
1998
), the depression of IC
currents by galanin is consistent with the loss of accommodation and
increase in excitability caused by this peptide under current-clamp
conditions.
|
Figure 4C (top) shows the reversible,
galanin-evoked depolarization of the membrane potential resulting in an
increased firing rate (approximately
4 Hz). In a majority of cells,
this depolarization was sufficient to bring the cell to threshold
leading to spontaneous firing of action potentials. In 20 DBB neurons,
application of 300 nM galanin resulted in depolarization of the RMP
from
66.9 ± 1.4 to
57.6 ± 2.4 mV with recovery to
64.1 ± 7.7 mV. We also examined whether galantide, a putative
antagonist for galanin, was able to block the excitatory effects of
galanin. In eight cells, application of galantide even at doses of
1-100 nM resulted in a membrane depolarization similar to that
observed for galanin (control RMP =
72.0 ± 2.2 mV, with
galantide RMP =
63.9 ± 1.9 mV, Fig. 4C,
middle). Iberiotoxin (25 nM), a blocker of
IC channels, applied to DBB neurons
also evoked a similar degree of membrane depolarization as galanin and
galantide (control RMP =
69.0 ± 1.4 mV, with iberitoxin
RMP =
59.5 ± 1.7 mV, n = 8, Fig.
4C, bottom).
| |
DISCUSSION |
|---|
|
|
|---|
The findings reported here provide the first electrophysiological evidence that the neuropeptide galanin causes an excitation of mammalian central neurons. Activation of galanin receptors results in membrane depolarization and an increase in excitability of basal forebrain neurons, that is related in part, through its effects in reducing specific voltage- and calcium-dependent potassium conductances (IC, IA, and IK). Furthermore, these actions of galanin are specific to cholinergic, and not GABAergic, basal forebrain neurons as identified by single-cell RT-PCR analysis.
Galanin modulation of ionic conductances and neuronal excitability
Several studies have examined the actions of galanin application
on CNS neurons, and with one exception these studies have identified an
inhibitory effect of this peptide. In the locus coeruleus, dorsal
raphe, hypothalamic supraoptic nucleus, and CA3 hippocampal neurons,
galanin caused a hyperpolarization of the postsynaptic membrane via a
potassium conductance (Konopka et al. 1989
; Papas
and Bourque 1997
; Pieribone et al. 1995
;
X. J. Xu et al. 1995
; Z. Q. Xu et al.
1999
) that was not specifically characterized but in locus
coeruleus and dorsal raphe neurons was TEA sensitive. In dorsal root
ganglion cells, galanin evoked an inward current that was accompanied
by an increase in input conductance, but the specific ionic conductance
underlying these effects was not identified (Puttick et al.
1994
).
Our data show that galanin affects a suite of potassium conductances in
basal forebrain DBB neurons. Among the potassium conductances affected,
galanin decreases IC currents without
influencing calcium currents and leads us to conclude that galanin has
a direct effect on IC channels,
similar to that we have previously observed for another peptide,
vasopressin, in this region (Easaw et al. 1997
). Since
IC provides a drive for the
repolarization phase of the action potential and plays an important
role in the process of spike frequency adaptation (accommodation)
(Vergara et al. 1998
), the galanin-induced blockade of
IC we observed here could explain the
increase in excitability and loss of accommodation in DBB neurons with
galanin. In addition, galanin consistently depolarized DBB neurons.
Inhibition of IC could contribute to
membrane depolarization induced by galanin because application of
iberiotoxin, a specific blocker IC or
BK channels also evoked a similar depolarizing response.
Fast-inactivating potassium channels
(IA) and the slower inactivating
IK are also important in modulating
neuronal excitability, in part, through their effects on the early
phase of spike repolarization (Storm 1990
).
Galanin-evoked inhibition of both IA
and IK could lead to an overall
increase in excitability of DBB neurons. Although galanin did not
influence Ca2+ currents, prolonged depolarization
resulting from a blockade of K+ currents could
also lead to increased total Ca2+ influx and
influence the excitability of the neuron.
Galanin receptor activation on cholinergic basal forebrain neurons
Our single-cell RT-PCR data indicate that the galanin-induced
reduction of whole cell currents and the increase in excitability is
specific to cholinergic and not GABA-synthesizing DBB neurons. Three
G-protein-coupled receptor subtypes for galanin have been cloned
(GALR1, GALR2, and GALR3) (for review, see Branchek et al.
2000
). Although both GALR1 and GALR2 have been localized in the
DBB (O'Donnell et al. 1999
), co-expression of GALR1 and
ChAT (a marker for cholinergic neurons) mRNAs was not detected in the basal forebrain nuclei (Miller 1998
). This suggests that
the effects of galanin on DBB neurons may be mediated via GALR2 or
possibly GALR3 receptors. We attempted to utilize galantide (M15) as a putative galanin antagonist, but even at relatively low doses, this
chimeric ligand acted as a galanin agonist causing membrane depolarization and increase in firing of DBB neurons. These galanin agonist-like actions have been reported in several previous studies using galantide and similar other chimeric galanin receptor ligands (Kask et al. 1995
; Kinney et al. 1998
;
Papas and Bourque 1997
). Development of
pharmacologically selective antagonists for the cloned galanin
receptors is necessary before a definitive characterization of the
receptor on cholinergic basal forebrain neurons is possible.
Functional implications of excitatory effects of galanin
Although the origin of the endogenous galanin input to the DBB is
unknown, the expression of galanin and its behavioral effects in the
cholinergic basal forebrain have become increasingly important in the
context of cognitive impairments seen in normal aging and diseases such
as AD. In AD, degeneration of cholinergic basal forebrain neurons,
which is linked to memory and spatial learning deficits, has been
associated with a parallel upregulation of galanin synthesis
(Mufson et al. 1998
). There is thus a galininergic hyperinnervation of the remaining cholinergic basal forebrain neurons
in the brains of AD patients (Chan-Palay 1988
). On the basis of galanin-induced inhibition of ACh release (Fisone et al. 1987
), it has been hypothesized that the increased galanin innervation of cholinergic neurons could play an important role in
worsening cognitive function of AD patients. This postulate fits with
some behavioral studies where central injections of galanin into the
DBB and medial septum result in disruption of short-term memory tasks
in rodents (Givens et al. 1992
; Mastropaolo et
al. 1988
) and the inhibitory actions of galanin at a cellular level that have been observed at CNS sites other than the basal forebrain.
Our findings of an excitatory effect of galanin on cholinergic basal
forebrain neurons, which are at the epicenter of pathology in AD,
cannot be reconciled with the above hypothesis. An alternative interpretation is that galanin overexpression in AD may serve a
compensatory role by augmenting the release of ACh from the remaining
cholinergic basal forebrain neurons. This notion is supported by the
observation that NGF, which rescues degenerating cholinergic neurons
and increases ACh turnover by upregulating ChAT synthesis
(Rylett et al. 1993
; Williams et al.
1986
), also induces galanin gene expression in the cholinergic
basal forebrain (Planas et al. 1997
). We suggest that
the such an increase in galanin, through its excitatory effects on the
cholinergic basal forebrain neurons, could cause increased release of
ACh, which would be entirely consistent with the trophic effects of NGF
on cholinergic function. Our findings would also explain the recent observation that adult mice carrying a targeted loss-of-function mutation in the galanin gene demonstrate deficits in cholinergic function and impairments in behavioral and electrophysiological tests
of memory (O'Meara et al. 2000
). An important
consequence of the findings presented here relates to the development
of galanin antagonists, which have been promoted as a possible
treatment option for AD. Our findings should inject a note of caution
in viewing such antagonists as "neuroprotective," a notion that is based on their potential to reverse the inhibitory effects of galanin,
which may be receptor and region specific in the CNS.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dr. W. Colmers for helpful comments and suggestions and C. Krys for assistance with preparation of the manuscript.
This research was supported by a grant from the Canadian Institutes for Health Research (MT-10473) and the University Hospitals Foundation. B. S. Jassar was supported by a postdoctoral fellowship award from the Alberta Heritage Foundation for Medical Research. J. H. Jhamandas is a recipient of Canada Research Chair in Medicine (Neurology).
| |
FOOTNOTES |
|---|
Address for reprint requests: J. H. Jhamandas, Div. of Neurology, 530 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta T6G 2S2, Canada (E-mail: jack.jhamandas{at}ualberta.ca).
Received 21 May 2001; accepted in final form 16 October 2001.
| |
REFERENCES |
|---|
|
|
|---|
a novel biologically active peptide from porcine intestine.
FEBS Lett
164:
124-128, 1983[ISI][Medline].This article has been cited by other articles:
![]() |
C. Hawkes, J. H. Jhamandas, K. H. Harris, W. Fu, R. G. MacDonald, and S. Kar Single Transmembrane Domain Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor Regulates Central Cholinergic Function by Activating a G-Protein-Sensitive, Protein Kinase C-Dependent Pathway J. Neurosci., January 11, 2006; 26(2): 585 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Robinson Galanin and Cognition Behav Cogn Neurosci Rev, December 1, 2004; 3(4): 222 - 242. [Abstract] [PDF] |
||||
![]() |
J. H. Jhamandas, K. H. Harris, C. Cho, W. Fu, and D. MacTavish Human Amylin Actions on Rat Cholinergic Basal Forebrain Neurons: Antagonism of Beta-Amyloid Effects J Neurophysiol, June 1, 2003; 89(6): 2923 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Counts, S. E. Perez, S. D. Ginsberg, S. de Lacalle, and E. J. Mufson Galanin in Alzheimer Disease Mol. Interv., May 1, 2003; 3(3): 137 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Chin, K. Harris, D. MacTavish, and J. H. Jhamandas Nociceptin/Orphanin FQ Modulation of Ionic Conductances in Rat Basal Forebrain Neurons J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 188 - 195. [Abstract] [Full Text] [PDF] |
||||
< |